Skip to main content
News Icon

Cluster goes Charity

Cluster goes Charity!

All of our cluster member were invited to collect bootle caps, which have have a certain amount of recyclable materials which can be reused.

Similar to gold this resource will be recycled and the earnings will be donated to the FÖRDERKREIS BONN E.V..
For more than 35 years, the Förderkreis Bonn e.V. has been at the side of young
patients of the oncology ward of the University Children’s Hospital Bonn. From overnight accommodation close to the clinic for parents, games, handicrafts, workshops or holiday periods for patients and their siblings, psycho-oncological and psychosocial counselling, palliative care to support for the paediatric oncology ward. (More information: https://www.foerderkreis-bonn.de/helfen/kronkorken-aktion/)

We want to say - Thank you! - to all our members who donated such a massive amount of bottle caps.

We are still happy to receive any bottle cap in our office located in the basement of BMZI.

Related news

News Icon

Publication

Twin Lancet Publications Highlight Promising New Approach for Lupus Treatment

—A team of international researchers, including ImmunoSensation³ member Prof. Jörg Wenzel, reports promising phase 2 results for enpatoran, a first-in-class oral TLR7/8 inhibitor, in patients with cutaneous and systemic lupus erythematosus (CLE/SLE). In the WILLOW trial, enpatoran significantly improved skin disease activity in a dose-dependent manner and showed favourable safety outcomes. In systemic SLE, treatment also reduced global disease activity and rapidly suppressed the type I interferon gene signature. The twin studies were published in The Lancet and The Lancet Rheumatology.
View entry
Wissenschaftler

Publication

Driver of inflammation after mild head injury

—Mild traumatic brain injuries can lead to persistent memory problems and an increased risk of dementia. Yet, effective therapies to counteract these long-term consequences are still lacking. Dr. Dr. Sergio Castro-Gomez, Early Career Research Group Leader at the Institute of Physiology II of the University Hospital Bonn has discovered together with colleagues that the ASC protein. The research team hopes to identify new targets for future therapeutic strategies. The study, published in the Journal of Clinical Investigation, lays the foundation for upcoming clinical trials.
View entry
Children in the lab at "Girls' and Boys' Day 2026"

Outreach

Girls' & Boys' Day at ImmunoSensation³

—The annual "Girls' & Boys' Day" (former "Girls' day") sets out to introduce children and young addults to careers their respective gender is still underrepresented in. To celebrate this special day and offer insights into the work of a biomedical researcher, we welcomed students from all over Germany to our laboratories. Besides hands-on science, career options and perspectives in research were discussed.
View entry

Back to the news overview